We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 7 februari 2018

Bone Marrow Transplantation - Table of Contents alert Volume 53 Issue n2

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation
TABLE OF CONTENTS

Volume 53, Issue 2 (February 2018)

In this issue
Commentary
Reviews
Special Report
Original Articles
Letters to the Editor
Corrigendum

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Commentary

Top

Recommendations for reporting post-transplant relapse in AML

A Rashidi, M A Linden, M-E Percival, B M Sandmaier, S Devine and D J Weisdorf

Bone Marrow Transplant 2018 53: 111-113; advance online publication, October 30, 2017; 10.1038/bmt.2017.227

Full Text

Reviews

Top

Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT

C Qian, Y Wang, L Reppel, M D'aveni, A Campidelli, V Decot and D Bensoussan

Bone Marrow Transplant 2018 53: 114-122; advance online publication, October 23, 2017; 10.1038/bmt.2017.232

Abstract | Full Text

Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies

S M Rubinstein, K A Culos, B Savani and G Satyanarayana

Bone Marrow Transplant 2018 53: 123-128; advance online publication, October 23, 2017; 10.1038/bmt.2017.222

Abstract | Full Text

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies

J Khosla, A C Yeh, T R Spitzer and B R Dey

Bone Marrow Transplant 2018 53: 129-137; advance online publication, October 2, 2017; 10.1038/bmt.2017.207

Abstract | Full Text

Special Report

Top

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation OPEN

S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, J-H Dalle, F Dignan, B Gibson, T Guengoer, B Gruhn, A Lankester, F Locatelli, A Pagliuca, C Peters, P G Richardson, A S Schulz, P Sedlacek, J Stein, K-W Sykora, J Toporski, E Trigoso, K Vetteranta, J Wachowiak, E Wallhult, R Wynn, I Yaniv, A Yesilipek, M Mohty and P Bader

Bone Marrow Transplant 2018 53: 138-145; advance online publication, July 31, 2017; 10.1038/bmt.2017.161

Abstract | Full Text

Original Articles

Top

Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation

A Kansagra, D J Inwards, S M Ansell, I N Micallef, P B Johnston, W J Hogan, S N Markovic and L F Porrata

Bone Marrow Transplant 2018 53: 146-154; advance online publication, October 16, 2017; 10.1038/bmt.2017.225

Abstract | Full Text

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

R Chakraborty, E Muchtar, S K Kumar, F K Buadi, D Dingli, A Dispenzieri, S R Hayman, W J Hogan, P Kapoor, M Q Lacy, N Leung and M A Gertz

Bone Marrow Transplant 2018 53: 155-161; advance online publication, November 13, 2017; 10.1038/bmt.2017.228

Abstract | Full Text

Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients

P Ke, X-B Bao, X-H Hu, J Zhuang, X-J Wu, Y-J Liu, X-F He, D-P Wu, S-L Xue and X Ma

Bone Marrow Transplant 2018 53: 162-168; advance online publication, October 30, 2017; 10.1038/bmt.2017.229

Abstract | Full Text

Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide

N A Fouzia, E S Edison, K M Lakshmi, A Korula, S R Velayudhan, P Balasubramanian, A Abraham, A Viswabandya, B George, V Mathews and A Srivastava

Bone Marrow Transplant 2018 53: 169-174; advance online publication, October 16, 2017; 10.1038/bmt.2017.231

Abstract | Full Text

NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma

B Jeker, U Novak, B Mansouri Taleghani, G M Baerlocher, K Seipel, B U Mueller, M Bigler, D Betticher, J-M Luethi, S Farese, A Ruefer and T Pabst

Bone Marrow Transplant 2018 53: 175-179; advance online publication, October 23, 2017; 10.1038/bmt.2017.234

Abstract | Full Text

The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients

E Albert, C Solano, E Giménez, D Focosi, A Pérez, L Macera, J L Piñana, J C H Boluda, F Maggi and D Navarro

Bone Marrow Transplant 2018 53: 180-187; advance online publication, October 30, 2017; 10.1038/bmt.2017.235

Abstract | Full Text

Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia

L-P Xu, Z-L Xu, F-R Wang, X-D Mo, T-T Han, W Han, Y-H Chen, Y-Y Zhang, J-Z Wang, Y Wang, C-H Yan, Y-Q Sun, F-F Tang, X-H Zhang and X-J Huang

Bone Marrow Transplant 2018 53: 188-192; advance online publication, January 15, 2018; 10.1038/bmt.2017.237

Abstract | Full Text

Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation

D N O'Dwyer, A S Duvall, M Xia, T C Hoffman, K S Bloye, C A Bulte, X Zhou, S Murray, B B Moore and G A Yanik

Bone Marrow Transplant 2018 53: 193-198; advance online publication, October 23, 2017; 10.1038/bmt.2017.238

Abstract | Full Text

Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact

M R Dowling, S Li, B R Dey, S L McAfee, H R Hock, T R Spitzer, Y-B Chen and K K Ballen

Bone Marrow Transplant 2018 53: 199-206; advance online publication, November 13, 2017; 10.1038/bmt.2017.239

Abstract | Full Text

Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies

D-Y Shin, J-H Lee, S Park, J-O Lee, J-H Moon, J-S Ahn, Y Choi, I-C Song, H-J Shin, W S Lee, H S Lee and S-S Yoon

Bone Marrow Transplant 2018 53: 207-212; advance online publication, October 30, 2017; 10.1038/bmt.2017.240

Abstract | Full Text

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

R Crocchiolo, O Ringden, J-O Bay, D Blaise, B Omasic, B Mazzi, C Picard, S Trinca, L Barkholt, J Peccatori, S Gregori, G Amodio, K Fleischhauer, F Ciceri and M Bregni on behalf of the STWP and CTIWP of EBMT

Bone Marrow Transplant 2018 53: 213-218; advance online publication, November 13, 2017; 10.1038/bmt.2017.243

Abstract | Full Text

Letters to the Editor

Top

Acute appendicitis in leukaemia patients undergoing haematopoietic stem cell transplantation during the neutropaenic phase: a case series from a single BMT centre in China

Q Zhang, Y Zhou, J K Majaw, J Xu, Z Wei, Q Mai, C Zou, Y Zhang, Z Fan, F Huang, J Sun, Q Liu and Q Jiang

Bone Marrow Transplant 2018 53: 219-222; advance online publication, January 22, 2018; 10.1038/bmt.2017.209

Full Text

Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation

T F Michniacki, J M Mulcahy Levy, R R Quinones and R H Giller

Bone Marrow Transplant 2018 53: 223-224; advance online publication, October 16, 2017; 10.1038/bmt.2017.219

Full Text

Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation

N Hiramoto, J Takeda, K Yoshida, Y Ono, S Yoshioka, N Yamauchi, A Fujimoto, H Maruoka, Y Shiraishi, H Tanaka, K Chiba, Y Imai, S Miyano, S Ogawa and T Ishikawa

Bone Marrow Transplant 2018 53: 225-227; advance online publication, October 9, 2017; 10.1038/bmt.2017.226

Full Text

Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk

A Re, G Gini, M Rupolo, A Levis, A Bandera, A M Liberati, P Tozzi, C Cattaneo, S Casari, C Skert, C Bocci, M Spina, B Allione, L Verga, M Michieli, C Almici, P F Leali, U Tirelli and G Rossi on behalf of GICAT and FIL

Bone Marrow Transplant 2018 53: 228-230; advance online publication, October 9, 2017; 10.1038/bmt.2017.230

Full Text

Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study

J Lehrer, E Brissot, A Ruggeri, R Dulery, A Vekhoff, G Battipaglia, F Giannotti, C Fernandez, M Mohty and M Antignac

Bone Marrow Transplant 2018 53: 231-233; advance online publication, November 20, 2017; 10.1038/bmt.2017.233

Full Text

Corrigendum

Top

Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

L Castagna, R Boubdallah, S Furst, D Coso, J El Cheikh, C Faucher, R Crocchiolo, A Granata, C Chabannon, C Lemarié, B Calmels, J M Boher, M Mohty and D Blaise

Bone Marrow Transplant 2018 53: 234; 10.1038/bmt.2018.1

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature